Cambridge, MA, United States of America

Eleni Dokou

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 10.0

ph-index = 7

Forward Citations = 180(Granted Patents)


Location History:

  • Newton, MA (US) (2021)
  • Cambridge, MA (US) (2013 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eleni Dokou in the Pharmaceutical Field

Introduction

Eleni Dokou is a prominent inventor based in Cambridge, MA, known for her significant contributions to the pharmaceutical industry. With a robust portfolio of 12 patents, she has made strides in developing innovative treatments for diseases such as cystic fibrosis. Her work exemplifies the intersection of scientific research and practical application, transformative for both patients and the medical field.

Latest Patents

Eleni's latest patents reflect her commitment to advancing therapeutic solutions. Her first notable patent is for a pharmaceutical composition that utilizes a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide. This composition includes formulations as powders, granules, and mini-tablets, aimed at improving treatment methods for cystic fibrosis.

Another significant patent involves pharmaceutical compositions designed for the treatment of cystic fibrosis transmembrane conductance regulator-mediated diseases. This invention features combinations of therapeutic agents, with one agent enhancing the effectiveness of another, including CFTR correctors and potentiators crucial for treating CFTR-mediated conditions.

Career Highlights

Eleni currently works at Vertex Pharmaceuticals, a leading company in the biotechnology sector focused on transformative medicines. Her innovative work has not only contributed to her patent portfolio but has also positioned her as a valued expert in pharmaceutical research and development.

Collaborations

Throughout her career, Eleni has collaborated with esteemed colleagues, including Dragutin Knezic and Lori Ann Ferris. These collaborations have enriched her research and helped streamline the development processes of her pharmaceutical compositions, forging a path for breakthroughs in treating chronic conditions like cystic fibrosis.

Conclusion

Eleni Dokou's dedication and innovative spirit have marked her as an influential figure in the field of pharmaceutical inventions. Her extensive work on patents aimed at treating cystic fibrosis has potential implications for improving patient care. As she continues her work at Vertex Pharmaceuticals, her contributions to science and medicine are likely to create a lasting impact on the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…